Cargando…
Novel Elongator Protein 2 Inhibitors Mitigating Tumor Necrosis Factor-α Induced Osteogenic Differentiation Inhibition
Tumor necrosis factor-α is a common cytokine that increases in inflammatory processes, slows the differentiation of bone formation, and induces osteodystrophy in the long-term inflammatory microenvironment. Our previous study confirmed that the Elongation protein 2 (ELP2) plays a significant role in...
Autores principales: | Wu, Wen-Jiao, Xia, Chang-Liang, Ou, Shuan-Ji, Yang, Yang, Ma, Yun-Fei, Hou, Yi-Long, Yang, Qing-Po, Zhang, Jun, Li, Jian-Wei, Qi, Yong, Xu, Chang-Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629650/ https://www.ncbi.nlm.nih.gov/pubmed/34853789 http://dx.doi.org/10.1155/2021/3664564 |
Ejemplares similares
-
Prophylactic Effects of NFκB Essential Modulator–Binding Domain Peptides on Bone Infection: An Experimental Study in a Rabbit Model
por: Wu, Wen-Jiao, et al.
Publicado: (2022) -
Discovery of novel elongator protein 2 inhibitors by compound library screening using surface plasmon resonance
por: Xu, Chang-Peng, et al.
Publicado: (2019) -
Apigenin Mitigates Intervertebral Disc Degeneration through the Amelioration of Tumor Necrosis Factor α (TNF-α) Signaling Pathway
por: Ding, Fan, et al.
Publicado: (2020) -
Clinical Significance of Tumor Necrosis Factor-α Inhibitors in the Treatment of Sciatica: A Systematic Review and Meta-Analysis
por: Wang, Yun Fu, et al.
Publicado: (2014) -
Inhibitor and substrate cooperate to inhibit amyloid fibril elongation of α-synuclein
por: Agerschou, Emil Dandanell, et al.
Publicado: (2020)